A Phase II Study of Erlotinib in Patients with Polycythaemia Vera and Essential Thrombocythemia.
Latest Information Update: 13 Nov 2013
At a glance
- Drugs Erlotinib (Primary)
- Indications Essential thrombocythaemia; Polycythaemia vera
- Focus Pharmacogenomic; Therapeutic Use
Most Recent Events
- 09 Aug 2011 New trial record